TaxTMI Login
Just a moment...
Press 'Enter' to add multiple search terms. Rules for Better Search
of 
of 
No Folders have been created
Are you sure you want to delete "My most important" ?
NOTE:
of of 
All News
of of All News
Note
Bookmark
Share
Don't have an account? Register Here
of <h1>Pharma Giant Achieves 12.4% Revenue Growth, Secures EUR200M European Contract Amid Market Challenges</h1> A pharmaceutical company reported strong financial performance in Q4 FY25, with 12.4% revenue growth and consolidated total income of Rs. 4,170 crore. The organization secured a significant EUR200 million European contract, invested Rs. 272 crore in capital expenditure, and maintained a robust R&D focus. Despite industry challenges like price erosion, the company remains committed to global expansion and innovation in pharmaceutical manufacturing.
TaxTMI 